Sunway Healthcare Holdings Berhad (KLSE:SUNMED)

KLSE:SUNMED Statistics

Total Valuation

KLSE:SUNMED has a market cap or net worth of MYR 21.85 billion. The enterprise value is 22.92 billion.

Market Cap	21.85B
Enterprise Value	22.92B

Important Dates

The next estimated earnings date is Friday, June 12, 2026.

Earnings Date	Jun 12, 2026
Ex-Dividend Date	n/a

Share Statistics

KLSE:SUNMED has 11.50 billion shares outstanding.

Current Share Class	11.50B
Shares Outstanding	11.50B
Shares Change (YoY)	n/a
Shares Change (QoQ)	-0.54%
Owned by Insiders (%)	0.11%
Owned by Institutions (%)	n/a
Float	2.29B

Valuation Ratios

The trailing PE ratio is 95.00 and the forward PE ratio is 71.97. KLSE:SUNMED's PEG ratio is 3.99.

PE Ratio	95.00
Forward PE	71.97
PS Ratio	10.44
PB Ratio	9.03
P/TBV Ratio	9.16
P/FCF Ratio	n/a
P/OCF Ratio	51.51
PEG Ratio	3.99

Enterprise Valuation

The stock's EV/EBITDA ratio is 50.03, with an EV/FCF ratio of -149.70.

EV / Earnings	105.04
EV / Sales	10.96
EV / EBITDA	50.03
EV / EBIT	78.79
EV / FCF	-149.70

Financial Position

The company has a current ratio of 1.10, with a Debt / Equity ratio of 0.66.

Current Ratio	1.10
Quick Ratio	0.99
Debt / Equity	0.66
Debt / EBITDA	3.46
Debt / FCF	-10.36
Interest Coverage	5.17

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	7.02%
Return on Capital Employed (ROCE)	7.65%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, KLSE:SUNMED has paid 53.89 million in taxes.

Income Tax	53.89M
Effective Tax Rate	19.80%

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	n/a
Average Volume (20 Days)	187,341,175

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KLSE:SUNMED had revenue of MYR 2.09 billion and earned 218.23 million in profits. Earnings per share was 0.02.

Revenue	2.09B
Gross Profit	1.29B
Operating Income	290.96M
Pretax Income	272.13M
Net Income	218.23M
EBITDA	452.33M
EBIT	290.96M
Earnings Per Share (EPS)	0.02

Balance Sheet

The company has 546.20 million in cash and 1.59 billion in debt, with a net cash position of -1.04 billion or -0.09 per share.

Cash & Cash Equivalents	546.20M
Total Debt	1.59B
Net Cash	-1.04B
Net Cash Per Share	-0.09
Equity (Book Value)	2.42B
Book Value Per Share	0.22
Working Capital	93.48M

Cash Flow

In the last 12 months, operating cash flow was 424.19 million and capital expenditures -577.33 million, giving a free cash flow of -153.14 million.

Operating Cash Flow	424.19M
Capital Expenditures	-577.33M
Free Cash Flow	-153.14M
FCF Per Share	-0.01

Margins

Gross margin is 61.83%, with operating and profit margins of 13.90% and 10.43%.

Gross Margin	61.83%
Operating Margin	13.90%
Pretax Margin	13.01%
Profit Margin	10.43%
EBITDA Margin	21.62%
EBIT Margin	13.90%
FCF Margin	n/a

Dividends & Yields

KLSE:SUNMED does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	283.31%
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	1.00%
FCF Yield	-0.70%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

KLSE:SUNMED has an Altman Z-Score of 0.74 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.74
Piotroski F-Score	3